GeoVax Labs develops vaccines that prevent and fight HIV infections that result in AIDS.

Biotechnology

Health Care

Medical Devices

GeoVax

GeoVax's headquarters in Smyrna, GA, United States

David A. Dodd

John W. Sharkey, PhD

Tom O'Brien

Mark Reynolds

Kelly McKee

John Niles

Randal D. Chase

John N. Spencer, Jr.

Dean G. Kollintzas

Robert T. Mcnally

The Leadership Team at GeoVax is responsible for setting the strategic direction of the company and overseeing the development of innovative vaccines for HIV prevention and treatment. This team collaborates closely to ensure effective business operations, regulatory compliance, and scientific advancements, ultimately aiming to improve public health outcomes related to AIDS.

Leadership Team

The Quality Assurance Team at GeoVax is responsible for ensuring that all vaccine development processes meet regulatory standards and internal quality benchmarks. Led by the Vice President and supported by multiple Directors, the team conducts rigorous testing, audits, and continuous monitoring to guarantee the safety, efficacy, and compliance of HIV-related vaccines, ultimately contributing to the firm's mission of combating AIDS.

Quality Assurance Team

The Vaccine Development Team at GeoVax focuses on creating innovative vaccine solutions to prevent and combat HIV infections that lead to AIDS. The team collaborates on research, design, and clinical trials, leveraging expertise in vector development and project management to advance novel vaccine candidates from concept to clinical application.

GeoVax

Org chart

Board & advisors

Teams

Leadership Team

Quality Assurance Team

Vaccine Development Team

Offices

GeoVax

Org chart

Board & advisors

Teams

Leadership Team

Quality Assurance Team

Vaccine Development Team

Offices

Related companies